Multi-Criteria Decision Analysis (MCDA) Models in Health Technology Assessment of Orphan Drugs-a Systematic Literature Review. Next Steps in Methodology Development?

about

Multi-Criteria Decision Analysis (MCDA) Models in Health Technology Assessment of Orphan Drugs-a Systematic Literature Review. Next Steps in Methodology Development?

Item

http://www.wikidata.org/entity/Q58122261

description

scientific article published on 15 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Multi-Criteria Decision Analys ...... ps in Methodology Development?

@en

Multi-Criteria Decision Analysis

@nl

type

Item

label

Multi-Criteria Decision Analys ...... ps in Methodology Development?

@en

Multi-Criteria Decision Analysis

@nl

prefLabel

Multi-Criteria Decision Analys ...... ps in Methodology Development?

@en

Multi-Criteria Decision Analysis

@nl

P1476

Multi-Criteria Decision Analys ...... ps in Methodology Development?

@en

P2093

Aleksandra Baran-Kooiker

http://www.w3.org/2001/XMLSchema#string

Coen Kooiker

http://www.w3.org/2001/XMLSchema#string

P2860

Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries

The quality of economic evaluations of ultra-orphan drugs in Europe - a systematic review

A review and classification of approaches for dealing with uncertainty in multi-criteria decision analysis for healthcare decisions

Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugs

Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications.

Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA.

The social burden and quality of life of patients with haemophilia in Italy.

Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.

Value-based reimbursement decisions for orphan drugs: a scoping review and decision framework.

Principles for consistent value assessment and sustainable funding of orphan drugs in Europe.

P304

287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPUBH.2018.00287

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marcin Czech

P577

2018-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30374435

http://www.w3.org/2001/XMLSchema#string

P921

orphan drug

P932

6197072

http://www.w3.org/2001/XMLSchema#string